Institut für Experimentelle und Klinische Pharmakologie und Toxikologie

Polypharmacology translates between species and phylogenetic distance: A functional, bioinformatic, and structural study on organic anion transporting polypeptides (2025) Stefan K, Namasivayam V, Akhter MT, Gyimesi G, Rafehi M, Busch H, Trombik T, et al. Journal article Role of Transport Proteins for the Renal Handling of L-Arginine and Related Derivatives (2025) Scherpinski L, König J, Maas R Journal article, Review article Gut-specific histamine 3 receptor signaling orchestrates microglia-dependent resolution of peripheral inflammation (2025) Dürholz K, Ehnes L, Linnerbauer M, Schmid E, Danzer H, Hinzpeter-Schmidt M, Lößlein L, et al. Journal article Distinct functional cerebral hypersensitivity networks during incisional and inflammatory pain in rats (2025) Kreitz S, Pradier B, Segelcke D, Amirmohseni S, Heß A, Faber C, Pogatzki-Zahn EM Journal article Pseudo-Worsening of Kidney Function (2025) Fromm M, Sponfeldner M, Dörje F, Geßner K, Dürr P, Cuba L, Schwanfelder J Journal article, Letter Clinical–pharmaceutical assessment of medication CDSS alerts: content appropriateness and patient relevance in clinical practice (2025) Bauer J, Busse M, Koch S, Schmid M, Sommer J, Fromm M, Dörje F Journal article Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in “Summaries of Product Characteristics” (2025) Andrikyan W, Sponfeldner M, Jung-Poppe L, Dürr P, Straubmeier MI, Schuster AK, Weisbach L, et al. Journal article From whole-brain metrics to circuitspecific precision: advancing fMRI biomarkers for TNF inhibitor response in rheumatoid arthritis – Authors' reply (2025) Heß A, Tascilar K, Schett G, Rech J Journal article Implications for medication safety and adherence in dermato-oncology: The AMBORA care program for oral antitumor therapeutics (2025) Cuba L, Dörje F, Kramer R, Dürr P, Erdmann M, Fromm M, Berking C, Geßner K Journal article Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study (2025) Heß A, Tascilar K, Schenker H, Konerth L, Schönau V, Sergeeva M, Kreitz S, et al. Journal article